Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05HWC
|
||||
Former ID |
DNC013485
|
||||
Drug Name |
PUKATEINE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528616] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H17NO3
|
||||
Canonical SMILES |
CN1CCC2=CC3=C(C4=C2C1CC5=C4C(=CC=C5)O)OCO3
|
||||
InChI |
1S/C18H17NO3/c1-19-6-5-11-8-14-18(22-9-21-14)17-15(11)12(19)7-10-3-2-4-13(20)16(10)17/h2-4,8,12,20H,5-7,9H2,1H3
|
||||
InChIKey |
IKMXUUHNYQWZBC-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 81-67-4
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [528616] | |
Dopamine D1 receptor | Target Info | Inhibitor | [528616] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Dopamine receptor mediated signaling pathway | |||||
Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.